# EDGAR Filing Document

**Accession Number:** 0001840439
**File Stem:** 0001193125-25-179812
**Filing Date:** 2025-8
**Character Count:** 1909
**Document Hash:** 0119f4e57a3fa068a0b3aec849037f97
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-179812.hdr.sgml**: 20250915

**ACCESSION NUMBER**: 0001193125-25-179812

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250813

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Biomea Fusion, Inc.
- **CENTRAL INDEX KEY:** 0001840439
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1599 INDUSTRIAL ROAD
- **CITY:** SAN CARLOS
- **STATE:** CA
- **ZIP:** 94070
- **BUSINESS PHONE:** (650) 980-9099

**MAIL ADDRESS:**
- **STREET 1:** 1599 INDUSTRIAL ROAD
- **CITY:** SAN CARLOS
- **STATE:** CA
- **ZIP:** 94070

Biomea Fusion, Inc.

1599 Industrial Road

San Carlos, CA 94070

August 13, 2025

**<u>VIA EDGAR</u>**

Securities and Exchange Commission

Division of Corporation Finance – Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Re: Biomea Fusion, Inc. Registration Statement on Form S-3 File No. 333-289262 <u>Request for Acceleration</u>

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biomea Fusion, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-289262) (the "Registration Statement"), so that it may become effective at 4:01 pm Eastern time on August 15, 2025, or as soon thereafter as practicable.

---

| | |
|:---|:---|
| Very truly yours,<br>BIOMEA FUSION, INC. | Very truly yours,<br>BIOMEA FUSION, INC. |
| By: | /s/ Michael J.M. Hitchcock, Ph.D. |
|  | Name: Michael J.M. Hitchcock, Ph.D. |
|  | Title: Interim Chief Executive Officer and Director |

---

Cc: Maggie Wong, Goodwin Procter LLP

Alicia Tschirhart, Goodwin Procter LLP